ArticleRheumatology and therapy2024

Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.

Ran Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.